![James Panek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Panek
Directeur/Membre du Conseil chez
SUTRO BIOPHARMA, INC.
Fortune : - $ au 31/05/2026
Profil
James P.
Panek is currently an Independent Director at Sutro Biopharma, Inc. since 2020 and Chief Operating Officer at CHO Plus, Inc. Formerly, Dr. Panek was Chairman & Co-Chief Executive Officer at Celltrion, Inc. from 2002 to 2006, President, Chief Executive Officer, CFO & Director at Diadexus, Inc. from 2010 to 2011, President, Chief Financial Officer, CAO & Director at VaxGen, Inc. from 2007 to 2010, Director at diaDexus, Inc., and Senior Vice President-Product Operations at Genentech, Inc. from 1982 to 2001.
Education includes undergraduate and graduate degrees from the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de James Panek
| Sociétés | Poste | Début |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Directeur/Membre du Conseil | 07/01/2020 |
Cho Plus, Inc.
 Cho Plus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops patented cell-engineering technologies for mammalian cells | Directeur des opérations | - |
Anciens postes connus de James Panek
| Sociétés | Poste | Fin |
|---|---|---|
| DIADEXUS, INC. | Directeur Général | 01/01/2011 |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products | Directeur/Membre du Conseil | 01/11/2010 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Directeur Financier/CFO | 01/01/2010 |
| CELLTRION, INC. | Directeur Général | 01/01/2006 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2001 |
Formation de James Panek
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltrion, Inc.
 Celltrion, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. Medical SpecialtiesHealth Technology Develops and commercializes patent-protected in vitro diagnostic products | Health Technology |
Cho Plus, Inc.
Cho Plus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops patented cell-engineering technologies for mammalian cells | Health Technology |
